Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 2 , Pages 89-93 , April 2010

Obesity and gestational diabetes

  • T. Sathyapalan

      Affiliations

    • Department of Diabetes, Endocrinology and Metabolism, Hull York Medical School, Hull, UK
    • ,
  • D. Mellor

      Affiliations

    • Department of Diabetes, Endocrinology and Metabolism, University of Hull, Hull, UK
    • ,
  • S.L. Atkin

      Affiliations

    • Department of Diabetes, Endocrinology and Metabolism, Hull York Medical School, Hull, UK
    • Corresponding Author InformationCorresponding author. Address: Michael White Centre for Diabetes, Brocklehurst Building, Hull Royal Infirmary, Anlaby Road, Hull HU3 2JZ, UK. Tel.: +44 1482 675365; Fax: +44 1482 5370.

References 

  1. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473–481
  2. King JC. Maternal obesity, metabolism, and pregnancy outcomes. Annu Rev Nutr. 2006;26:271–291
  3. Ehrenberg HM, Dierker L, Milluzzi C, et al. Prevalence of maternal obesity in an urban center. Am J Obstet Gynecol. 2002;187:1189–1193
  4. Gross T, Sokol RJ, King KC. Obesity in pregnancy: risks and outcome. Obstet Gynecol. 1980;56:446–450
  5. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. J Am Med Assoc. 1997;278:1078–1083
  6. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr. 2000;71:1242S–1248S
  7. Maggard MA, Yermilov I, Li Z, et al. Pregnancy and fertility following bariatric surgery: a systematic review. J Am Med Assoc. 2008;300:2286–2296
  8. Glazer NL, Hendrickson AF, Schellenbaum GD, et al. Weight change and the risk of gestational diabetes in obese women. Epidemiology. 2004;15:733–737
  9. Major CA, deVeciana M, Weeks J, et al. Recurrence of gestational diabetes: who is at risk?. Am J Obstet Gynecol. 1998;179:1038–1042
  10. Hedderson MM, Williams MA, Holt VL, et al. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol. 2008;198:409 e401–7
  11. Cundy T, Gamble G, Townend K, et al. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med. 2000;17:33–39
  12. Sheiner E, Levy A, Menes TS, et al. Maternal obesity as an independent risk factor for caesarean delivery. Paediatr Perinat Epidemiol. 2004;18:196–201
  13. Garcia-Patterson A, Erdozain L, Ginovart G, et al. In human gestational diabetes mellitus congenital malformations are related to pre-pregnancy body mass index and to severity of diabetes. Diabetologia. 2004;47:509–514
  14. Clausen TD, Mathiesen ER, Hansen T, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009;94:2464–2470
  15. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–2486
  16. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002
  17. Ornoy A. Growth and neurodevelopmental outcome of children born to mothers with pregestational and gestational diabetes. Pediatr Endocrinol Rev. 2005;3:104–113
  18. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007;30(Suppl. 2):S169–S174
  19. O'Sullivan JB. Body weight and subsequent diabetes mellitus. J Am Med Assoc. 1982;248:949–952
  20. American Diabetes Association . Gestational diabetes mellitus. Diabetes Care. 2004;27:s88–s90
  21. Jovanovic-Peterson L, Peterson CM. Nutritional management of the obese gestational diabetic pregnant woman. J Am Coll Nutr. 1992;11:246–250
  22. Knopp RH, Magee MS, Raisys V, et al. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes. 1991;40(Suppl. 2):165–171
  23. Cheng YW, Chung JH, Kurbisch-Block I, et al. Gestational weight gain and gestational diabetes mellitus: perinatal outcomes. Obstet Gynecol. 2008;112:1015–1022
  24. Peterson CM, Jovanovic-Peterson L. Percentage of carbohydrate and glycemic response to breakfast, lunch, and dinner in women with gestational diabetes. Diabetes. 1991;40(Suppl. 2):172–174
  25. Jovanovic-Peterson L, Peterson CM. Dietary manipulation as a primary treatment strategy for pregnancies complicated by diabetes. J Am Coll Nutr. 1990;9:320–325
  26. Walkinshaw SA. Dietary regulation for ‘gestational diabetes’. Cochrane Database Syst Rev. 2000;CD000070
  27. de Veciana M, Major CA, Morgan MA, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 1995;333:1237–1241
  28. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development – Diabetes in Early Pregnancy Study. Am J Obstet Gynecol. 1991;164:103–111
  29. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–e296
  30. Lurie S, Mamet Y. Red blood cell survival and kinetics during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2000;93:185–192
  31. Horton ES. Exercise in the treatment of NIDDM. applications for GDM?. Diabetes. 1991;40(Suppl. 2):175–178
  32. Kjos SL, Schaefer-Graf U, Sardesi S, et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001;24:1904–1910
  33. Bonomo M, Cetin I, Pisoni MP, et al. Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial. Diabetes Metab. 2004;30:237–244
  34. Nachum Z, Ben-Shlomo I, Weiner E, et al. Twice daily versus four times daily insulin dose regimens for diabetes in pregnancy: randomised controlled trial. Br Med J. 1999;319:1223–1227
  35. Nicholson WK, Wilson LM, Witkop CT, et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid Rep Technol Assess (Full Rep). 2008;1–96
  36. Garcia-Bournissen F, Feig DS, Koren G. Maternal–fetal transport of hypoglycaemic drugs. Clin Pharmacokinet. 2003;42:303–313
  37. Langer O, Yogev Y, Xenakis EM, et al. Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol. 2005;192:134–139
  38. Gilbert C, Valois M, Koren G. Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril. 2006;86:658–663
  39. Rowan JA, Hague WM, Gao W, et al. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med. 2008;358:2003–2015
  40. Glueck CJ, Wang P, Goldenberg N, et al. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17:2858–2864
  41. Glueck CJ, Pranikoff J, Aregawi D, et al. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome. Fertil Steril. 2008;89:625–634
  42. Kjos SL, Peters RK, Xiang A, et al. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus. J Am Med Assoc. 1998;280:533–538
  43. Moses RG. The recurrence rate of gestational diabetes in subsequent pregnancies. Diabetes Care. 1996;19:1348–1350
  44. MacNeill S, Dodds L, Hamilton DC, et al. Rates and risk factors for recurrence of gestational diabetes. Diabetes Care. 2001;24:659–662
  45. Catalano PM, Vargo KM, Bernstein IM, et al. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165:914–919
  46. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–1868
  47. Ferber KM, Keller E, Albert ED, et al. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. J Clin Endocrinol Metab. 1999;84:2342–2348
  48. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care. 2003;26:2005–2009
  49. Guideline Development Group . Management of diabetes from preconception to the postnatal period: summary of NICE guidance. Br Med J. 2008;336:714–717

PII: S1744-165X(09)00088-2

doi: 10.1016/j.siny.2009.09.002

Seminars in Fetal & Neonatal Medicine
Volume 15, Issue 2 , Pages 89-93 , April 2010

Article Tools